Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial.
PLoS One
; 17(3): e0264727, 2022.
Article
in En
| MEDLINE
| ID: mdl-35239732
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phosphates
/
Anemia, Iron-Deficiency
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
PLoS One
Journal subject:
CIENCIA
/
MEDICINA
Year:
2022
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Estados Unidos